Lawrence Lamb

All filings by Lawrence Lamb on record concern In8bio, Inc., in the capacity of senior executive. The record holds 3 filings, for trades running from 5 May 2022 to 13 December 2023.

Purchases make up the whole of the open-market record (1 purchase, €983). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 1 share grant and 1 option exercise.

The newest entry dates from 15 December 2023: a share grant, in In8bio, Inc. The latest purchase dates back some time: it was published 1,528 days ago, on 18 August 2022. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.